These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 18593578

  • 1. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P, Shahidi S, Komaki A, Mirazi N.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):132-5. PubMed ID: 18593578
    [Abstract] [Full Text] [Related]

  • 2. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis.
    Hasanein P, Javanmardi K.
    Fundam Clin Pharmacol; 2008 Oct 04; 22(5):517-22. PubMed ID: 18844724
    [Abstract] [Full Text] [Related]

  • 3. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 04; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

  • 4. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
    Hasanein P, Parviz M, Keshavarz M, Javanmardi K, Allahtavakoli M, Ghaseminejad M.
    Eur J Pharmacol; 2007 Jan 12; 554(2-3):123-7. PubMed ID: 17107671
    [Abstract] [Full Text] [Related]

  • 5. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.
    Hasanein P.
    Neurosci Lett; 2009 Oct 25; 462(3):230-4. PubMed ID: 19616063
    [Abstract] [Full Text] [Related]

  • 6. Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
    Hasanein P.
    J Psychopharmacol; 2011 Feb 25; 25(2):281-8. PubMed ID: 19825905
    [Abstract] [Full Text] [Related]

  • 7. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW.
    Br J Pharmacol; 2006 Feb 25; 147(3):281-8. PubMed ID: 16331291
    [Abstract] [Full Text] [Related]

  • 8. URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats.
    Hasanein P, Parviz M, Keshavarz M, Roohbakhsh A.
    Can J Physiol Pharmacol; 2009 Jun 25; 87(6):432-9. PubMed ID: 19526037
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, Sagar DR, Bennett AJ, Alexander SP, Kendall DA, Barrett DA, Chapman V.
    Neuropharmacology; 2008 Jul 25; 55(1):85-93. PubMed ID: 18534634
    [Abstract] [Full Text] [Related]

  • 10. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181
    [Abstract] [Full Text] [Related]

  • 11. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
    Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Biol Psychiatry; 2007 Nov 15; 62(10):1103-10. PubMed ID: 17511970
    [Abstract] [Full Text] [Related]

  • 12. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    Naidu PS, Booker L, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Apr 15; 329(1):48-56. PubMed ID: 19118134
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
    Nasirinezhad F, Jergova S, Pearson JP, Sagen J.
    Neuropharmacology; 2015 Aug 15; 95():100-9. PubMed ID: 25486617
    [Abstract] [Full Text] [Related]

  • 14. Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.
    Holt S, Comelli F, Costa B, Fowler CJ.
    Br J Pharmacol; 2005 Oct 15; 146(3):467-76. PubMed ID: 16100529
    [Abstract] [Full Text] [Related]

  • 15. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 15; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 16. Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease.
    Johnston TH, Huot P, Fox SH, Wakefield JD, Sykes KA, Bartolini WP, Milne GT, Pearson JP, Brotchie JM.
    J Pharmacol Exp Ther; 2011 Feb 15; 336(2):423-30. PubMed ID: 20966038
    [Abstract] [Full Text] [Related]

  • 17. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V.
    Int Rev Neurobiol; 2009 Feb 15; 85():57-72. PubMed ID: 19607961
    [Abstract] [Full Text] [Related]

  • 18. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
    Jhaveri MD, Richardson D, Kendall DA, Barrett DA, Chapman V.
    J Neurosci; 2006 Dec 20; 26(51):13318-27. PubMed ID: 17182782
    [Abstract] [Full Text] [Related]

  • 19. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL, Cichewicz DL, Welch SP.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):60-8. PubMed ID: 16919265
    [Abstract] [Full Text] [Related]

  • 20. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov 28; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.